TTY Biopharm Company Limited Profit Margin

The latest profit margin for 4105.TWO is 26.38% as of June 2026. That compares with 25.46% in the prior-year period — up 3.6% year over year. That is above the sector sector average of 13.2%. Investors often review this figure alongside TTY Biopharm Company Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4105.TWO's profit margin moved from 25.46% to 26.38% — a 3.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TTY Biopharm Company Limited's valuation or profitability profile.

Against its sector companies, 4105.TWO currently prints 26.38% for profit margin, while the sector average sits near 13.2%. That is roughly 99.8% above the sector mean. Large gaps often invite a closer look at TTY Biopharm Company Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively TTY Biopharm Company Limited converts resources into returns. At 26.38%, 4105.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 25.46% in the prior-year period — up 3.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 4105.TWO's profit margin (26.38%), review year-over-year change from 25.46%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.